Delivery Order SPE2DR25D3202-SPE2DR26F8E3V
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 10 mg capsules (100 count) with a contract ceiling value of $1,973.26. This firm fixed-price delivery order, with an ultimate completion date of December 10, 2025, will be performed at the contractor's facility in Conshohocken, Pennsylvania. The award utilized no set-aside designation and was competitively awarded through an open procurement...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,131.09. This is a firm fixed price delivery order with no set-aside designation, issued competitively. The place of performance is AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, with an ultimate completion date of December 15, 2025. This delivery order is...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 9, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $1,185.70. This competitively awarded, firm fixed-price delivery order is scheduled for completion by December 10, 2025, with performance taking place at AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. The award represents a continuation of the vendor's critical role as a...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on November 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a ceiling value of $1,460.67. This is a firm fixed-price delivery order with an ultimate completion date of November 19, 2025, and represents a non-set-aside competitive award. The product will be delivered to AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a $1,387.60 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 15, 2025, for the supply of dextroamphetamine-amphetamine 30 mg capsules (100-count units). This is a non-set-aside competitive award with an ultimate completion date of December 16, 2025, and performance is based in Conshohocken, Pennsylvania, the company's headquarters location. The delivery order falls under AmerisourceBergen's broader Indefinite Delivery Contract...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 18, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100-count units) with a contract ceiling value of $1,594.31. This firm fixed-price delivery order, which is set to be completed by December 19, 2025, will be fulfilled from the vendor's location in Conshohocken, Pennsylvania. The award was made on a non-set-aside, competitive basis and represents a child contract under...
- The Defense Logistics Agency awarded a $1,707.46 delivery order to AmerisourceBergen Drug Corp on December 10, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100 count). This firm fixed-price contract, which carries an ultimate completion date of December 11, 2025, represents a non-set-aside competitive award to be performed at the vendor's corporate office location in Conshohocken, Pennsylvania. The delivery order is issued under AmerisourceBergen's larger Indefinite...
- The Defense Logistics Agency awarded a delivery order valued at $1,303.57 to AmerisourceBergen Drug Corp for the supply of dextroamphetamine-amphetamine 15 mg capsules (100 count) on December 19, 2025, with completion scheduled for December 22, 2025. This competitively awarded, firm fixed-price contract with no set-aside designation reflects standard pharmaceutical procurement operations supporting federal healthcare systems. The product will be delivered to AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 29, 2025, for the supply of Dextroamphetamine-Amphetamine 20 mg capsules (100-count) valued at $2,156.08. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract. The order is scheduled for completion by December 30, 2025, and will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child...
- The Defense Logistics Agency awarded a $3,449.76 firm fixed-price delivery order to AmerisourceBergen Drug Corp on December 12, 2025, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count). The contract is a non-set-aside competitive award with a completion date of December 15, 2025, and will be performed at the contractor's facility in Conshohocken, Pennsylvania. This delivery order represents a child contract issued under AmerisourceBergen's larger Indefinite Delivery...
- SPE2DR25D3202Indefinite Delivery Contract
- SPE2DR25D3202-SPE2DR26F8E3VDelivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on January 6, 2026, for the supply of Dextroamphetamine-Amphetamine 15 mg capsules (100 count) with a ceiling value of $2,975.09. This is a firm fixed-price delivery order with no set-aside designation, indicating the award was made through full and open competition. The place of performance is located in Conshohocken, Pennsylvania, where AmerisourceBergen Drug Corp maintains its corporate headquarters. This delivery order is issued under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2031, which serves as the primary vehicle for supplying comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. AmerisourceBergen Drug Corp is a major pharmaceutical distributor and healthcare solutions provider that serves as a critical vendor for federal medical procurement needs, particularly for military and veteran healthcare systems. Through its extensive federal contract portfolio with the Defense Logistics Agency and its Medical Supply Chain, the company demonstrates capability in delivering a broad spectrum of pharmaceutical products across multiple therapeutic domains, including controlled substances, specialty medications, vaccines, and medical supplies. The delivery order completion date is set for January 7, 2026, representing a routine pharmaceutical supply transaction supporting the Department of Defense's medical supply chain operations.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 1/5/26 |